963 related articles for article (PubMed ID: 19782075)
1. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
2. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
3. Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.
Vossel KA; Xu JC; Fomenko V; Miyamoto T; Suberbielle E; Knox JA; Ho K; Kim DH; Yu GQ; Mucke L
J Cell Biol; 2015 May; 209(3):419-33. PubMed ID: 25963821
[TBL] [Abstract][Full Text] [Related]
4. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
5. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
6. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
[TBL] [Abstract][Full Text] [Related]
8. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
DaRocha-Souto B; Coma M; Pérez-Nievas BG; Scotton TC; Siao M; Sánchez-Ferrer P; Hashimoto T; Fan Z; Hudry E; Barroeta I; Serenó L; Rodríguez M; Sánchez MB; Hyman BT; Gómez-Isla T
Neurobiol Dis; 2012 Jan; 45(1):425-37. PubMed ID: 21945540
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid1-42 gene transfer model exhibits intraneuronal amyloid, gliosis, tau phosphorylation, and neuronal loss.
Rebeck GW; Hoe HS; Moussa CE
J Biol Chem; 2010 Mar; 285(10):7440-6. PubMed ID: 20071340
[TBL] [Abstract][Full Text] [Related]
10. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
Zhang T; Xia Y; Hu L; Chen D; Gan CL; Wang L; Mei Y; Lan G; Shui X; Tian Y; Li R; Zhang M; Lee TH
Int J Biol Sci; 2022; 18(2):693-706. PubMed ID: 35002518
[TBL] [Abstract][Full Text] [Related]
11. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
[TBL] [Abstract][Full Text] [Related]
13. Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: implications to synaptic dysfunction and neuronal damage.
Manczak M; Reddy PH
J Alzheimers Dis; 2013; 36(2):285-95. PubMed ID: 23594602
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.
Zheng WH; Bastianetto S; Mennicken F; Ma W; Kar S
Neuroscience; 2002; 115(1):201-11. PubMed ID: 12401334
[TBL] [Abstract][Full Text] [Related]
17. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.
Sofola O; Kerr F; Rogers I; Killick R; Augustin H; Gandy C; Allen MJ; Hardy J; Lovestone S; Partridge L
PLoS Genet; 2010 Sep; 6(9):e1001087. PubMed ID: 20824130
[TBL] [Abstract][Full Text] [Related]
20. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
